There was a lot of hope at the start of 2021: COVID-19 vaccines had just arrived, an end to the pandemic seemed on the horizon, and a fresh start for the global economy was ahead. By now, it feels like much of January’s optimism was as inflated as today’s prices. But in the spirit of starting the ne...

At first glance, it may seem as if the world will soon have more than enough COVID-19 vaccines. Manufacturers have produced approximately ten billion individual doses since states began approving inoculations in the middle of 2020.

In the fifth installment of the Future of Development series, which brings together experts to discuss the big questions facing developing countries over the next decade, Leonard Wantchekon and Sarah Khan took on the role of politics in development (and vice versa), exploring how political distortio...

As the year draws to a close, the temptation to claim wisdom from adversity and experience becomes irresistible. We did it last year, by exploring what we learnt while the world burned around us. 2021 was perhaps a marginal improvement: not quite the best of times, but not quite the worst of times, ...

We congratulate the FCDO on the landmark paper on Health Systems Strengthening (HSS) and offer three recommendations for implementation: 1) further clarify strategic priorities, for example by articulating a poverty focus and prioritising partnership with low-and middle-income governments; 2) p...

High-income countries play a key role in the global response to Omicron. Their decisions can help increase global vaccination coverage, curb the spread of current variants, and prevent the emergence of new ones. Here we outline three actions high-income countries should take to help end the pandemic...